Sale!

LRBA Gene Immunodeficiency common variable type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LRBA gene immunodeficiency common variable type 8 genetic test is a specialized diagnostic procedure designed to identify mutations in the LRBA gene, which are associated with a type of primary immunodeficiency known as common variable immunodeficiency-8 (CVID-8). This condition is characterized by low levels of serum immunoglobulins (antibodies) leading to an increased susceptibility to infections, autoimmune disorders, and potentially an increased risk of malignancy. Patients with mutations in the LRBA gene may exhibit symptoms ranging from recurrent infections to more severe immune system dysfunctions.

The test is conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed using state-of-the-art genetic sequencing technologies to detect mutations in the LRBA gene. This genetic test is crucial for the accurate diagnosis of CVID-8, enabling healthcare providers to tailor treatment strategies to the specific needs of the patient, which may include immunoglobulin replacement therapy, medications to boost the immune system, and other supportive therapies.

The cost of the LRBA gene immunodeficiency common variable type 8 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the presence of any genetic mutations in the LRBA gene. Early diagnosis and intervention through this genetic test can significantly improve the quality of life for individuals with CVID-8 by reducing the frequency of infections and managing associated symptoms more effectively.

Description

LRBA Gene Immunodeficiency common variable type 8 Genetic Test

Components: LRBA Gene Immunodeficiency common variable type 8 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for LRBA Gene Immunodeficiency common variable type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LRBA Gene Immunodeficiency common variable type 8 NGS Genetic DNA Test gene LRBA

Test Details: The LRBA gene is associated with a rare immunodeficiency disorder called common variable immunodeficiency type 8 (CVID8). CVID8 is characterized by a defect in the LRBA gene, which leads to impaired immune system function and recurrent infections. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes, including the LRBA gene, to identify any mutations or abnormalities that may be present. This type of testing can help diagnose CVID8 and provide information about the specific genetic mutation causing the disorder. NGS genetic testing for LRBA gene immunodeficiency involves collecting a DNA sample, typically through a blood or saliva sample, and analyzing the DNA sequence using advanced sequencing technology. The test can detect various types of genetic mutations in the LRBA gene, including point mutations, insertions, deletions, and gene rearrangements. By identifying the specific genetic mutation in the LRBA gene, NGS genetic testing can help guide treatment decisions and provide information about the inheritance pattern of the disorder. It can also be used for carrier testing and prenatal diagnosis in families with a history of CVID8. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing for LRBA gene immunodeficiency is appropriate and to understand the implications of the test results.

Test Name	LRBA Gene Immunodeficiency common variable type 8 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for LRBA Gene Immunodeficiency common variable type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LRBA Gene Immunodeficiency common variable type 8 NGS Genetic DNA Test gene LRBA
Test Details	The LRBA gene is associated with a rare immunodeficiency disorder called common variable immunodeficiency type 8 (CVID8). CVID8 is characterized by a defect in the LRBA gene, which leads to impaired immune system function and recurrent infections. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes, including the LRBA gene, to identify any mutations or abnormalities that may be present. This type of testing can help diagnose CVID8 and provide information about the specific genetic mutation causing the disorder. NGS genetic testing for LRBA gene immunodeficiency involves collecting a DNA sample, typically through a blood or saliva sample, and analyzing the DNA sequence using advanced sequencing technology. The test can detect various types of genetic mutations in the LRBA gene, including point mutations, insertions, deletions, and gene rearrangements. By identifying the specific genetic mutation in the LRBA gene, NGS genetic testing can help guide treatment decisions and provide information about the inheritance pattern of the disorder. It can also be used for carrier testing and prenatal diagnosis in families with a history of CVID8. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing for LRBA gene immunodeficiency is appropriate and to understand the implications of the test results.